Supply chain technology provider noted for delivering value through deep functionality and industry-specific capabilities. MONTREAL, Nov. 22, 2023 /CNW/ -- Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, has been recognized in the inaugural Nucleus Research WMS Technology Value Matrix for 2023, where it has been placed in the "Expert" quadrant. According to the technology research and advisory firm, Tecsys distinguishes itself from competitors due to its advanced capabilities, deep functionality, and Distribution and Healthcare-specific industry expertise. TECSYS (PRNewsfoto/TECSYS) The Nucleus Research WMS Technology Value Matrix offers a comparative ranking of significant vendors within a market to provide empirical guidance in the WMS vendor selection process. Vendors are assessed based on two critical value drivers: usability and functionality. These vendors are categorized into one of four groups: Leaders, Experts, Facilitators, or Core Providers. According to Nucleus Research, "With advanced order fulfillment capabilities, real-time inventory visibility, and data analytics, leading WMS solutions are tailoring development toward warehouse optimization, empowering companies to handle direct-to-consumer e-commerce, omnichannel models, and global logistics requirements." Nucleus Research's "Expert" quadrant is reserved for providers offering comprehensive WMS solutions with deep functional capabilities adaptable to diverse industries. Tecsys' expertise spans multiple sectors, underscoring its versatility and holistic approach to optimizing supply chains. "Tecsys' WMS is a blend of robust functionality and user-friendly design," added Charles Brennan, research analyst for Supply Chain at Nucleus Research. "The company's commitment to an industry-tailored approach, especially in areas like Healthcare, Pharmacy and Complex 3PL, sets the standard in its space. Tecsys' leading position in its key industries is an indication of the organization's ability to anticipate and meet the evolving demands of a dynamic market, driving both efficiency and growth for its customers." Bill Denbigh, VP GTM Strategy for Tecsys, commented, "We are honored to be recognized as an Expert by Nucleus Research in its 2023 WMS Value Matrix. Tecsys has been equipping supply chains for real-world scenarios for over 40 years, and we've done this by applying the right mix of innovation and experience. This translates into robust functionality capable of tackling complexity while providing a simplified user experience." Tecsys' Elite™ WMS is built on the low-code Itopia® platform designed to provide comprehensive operational flexibility while enabling sophisticated supply chain execution. Elite™ WMS streamlines warehouse operations and optimizes receiving, order picking, and shipping while enhancing visibility and reducing labor costs. Tecsys empowers organizations with predictive analytics, dashboards, digital twins, heatmaps, and optimization recommendations, facilitating data-driven decisions and streamlined operations to deliver maximum value throughout the supply chain. For more information about Tecsys and its advanced supply chain solutions, please visit www.tecsys.com. For more information on the Nucleus Research WMS Technology Value Matrix, visit https://nucleusresearch.com/research/single/wms-technology-value-matrix-2023/. About Tecsys Since our founding 40 years ago, much has changed in the realm of supply chain technology. But one thing has remained constant; by developing dynamic and innovative supply chain solutions, Tecsys has been equipping organizations for growth and competitive advantage. Serving healthcare, distribution and converging commerce industries, and spanning multiple complex, regulated and high-volume markets, Tecsys delivers warehouse management, distribution and transportation management, supply management at point of use, and retail order management, as well as complete financial management and analytics solutions. Tecsys' shares are listed on the Toronto Stock Exchange under the ticker symbol TCS. For more information on Tecsys, visit www.tecsys.com. Copyright © Tecsys Inc. 2023. All names, trademarks, products, and services mentioned are registered or unregistered trademarks of their respective owners. Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tecsys-recognized-as-an-expert-in-nucleus-researchs-inaugural-2023-wms-technology-value-matrix-301995398.html SOURCE Tecsys Inc. Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2023/22/c1500.html
Tecsys Recognized as an Expert in Nucleus Research's Inaugural 2023 WMS Technology Value Matrix
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...